Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques
Frontiers in Microbiology · 02.06.2025 · 16
DOI: 10.3389/fmicb.2025.1592647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 02.06.2025. Verfasst von Jessica Coppola und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutrali…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, Gates Foundation.
Abstract (Originalsprache)
A vaccine is considered essential for controlling the HIV pandemic and ultimately eradicating AIDS. Neutralizing antibodies and MHC-E-restricted CD8+ T cells have shown the ability to protect against the simian counterpart of HIV, SIV, in rhesus macaques. In this study, we provide preliminary evidence that combining these orthogonal antiviral mechanisms can offer increased protection against SIV. Specifically, the replication arrest observed following vaccination with a rhesus cytomegalovirus (RhCMV/SIV)-based vaccine was enhanced by the presence of a passively administered neutralizing antibody at incompletely protective levels. This report encourages studies involving larger cohorts of macaques and alternative methods for administering neutralizing antibodies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States.
- Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
- AIDS and Cancer Virus Program, Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, United States.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- Gates Foundation
- NIH HHS
Zitieren
APA
Coppola, J., Parren, M., Bastidas, R., Saye, K., Malvin, J., Jardine, J. G., Gilbride, R. M., Ojha, S., Feltham, S., Morrow, D., Barber-Axthelm, A., Bochart, R., Fast, R., Oswald, K., Shoemaker, R., Lifson, J. D., Picker, L. J., Burton, D. R., & Hansen, S. G. (2025). Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1592647
Vancouver
Coppola J, Parren M, Bastidas R, Saye K, Malvin J, Jardine JG, et al. Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1592647
BibTeX
@article{Coppola2025,
author = {Coppola, Jessica and Parren, Mara and Bastidas, Raiza and Saye, Karen and Malvin, Jacqueline and Jardine, Joseph G and Gilbride, Roxanne M and Ojha, Sohita and Feltham, Shana and Morrow, David and Barber-Axthelm, Aaron and Bochart, Rachele and Fast, Randy and Oswald, Kelli and Shoemaker, Rebecca and Lifson, Jeffrey D and Picker, Louis J and Burton, Dennis R and Hansen, Scott G},
title = {Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1592647}
}
EUVIMED